
Ipca Laboratories Investor Relations Material
Latest events

Q3 24/25
Ipca Laboratories
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Ipca Laboratories Limited
Access all reports
Ipca Laboratories Limited is an India-based pharmaceutical company engaged in the manufacturing and marketing of active pharmaceutical ingredients and finished dosage forms. The company’s products cover therapeutic segments such as pain management, cardiovascular, anti-malarial, anti-infective, and dermatology. Ipca serves domestic and international markets, supplying to both branded and generic sectors, and also operates in the institutional supply segment. The company is headquartered in Mumbai, India, and its shares are listed on the BSE.
Latest articles
)
Upcoming IPOs to Watch in 2025
Potential IPOs in 2025 include prominent names like Shein, Databricks, Klarna, eToro, and Figma, to name a few. Let's take a closer look.
23 May 2025
)
Figma: Collaborative Design Tool Ready for IPO
Figma, the popular design platform, is preparing for a potential IPO in 2025 as it continues to reshape the future of collaborative design.
22 May 2025
)
Companies That Had Their IPO in 2024: Momentum Increasing
2024 marked a steady year for IPOs, driven by strong markets, AI momentum, and high-profile listings across industries and regions.
22 May 2025
Ticker symbol
IPCALAB
Country
🇮🇳 India